Backed by More Independent Research Than Any Other Oral Appliance

• One of the largest oral appliance studies ever conducted (497 patients) — U.S. Army health system
• Head-to-head comparison of TAP and CPAP in OSA treatment
• TAP showed effective apnea reduction with significantly better tolerability
• Quality-of-life and daytime sleepiness outcomes comparable to CPAP
• Patients preferred TAP due to comfort and ease of use

For patients who struggle with a CPAP mask: TAP delivers equivalent results — without the machine, the noise, or the hoses.

Key finding: Equivalent quality-of-life outcomes to CPAP, with superior patient preference and long-term adherence — proven at scale across one of the largest and most rigorous oral appliance trials ever conducted.

• Direct comparison of oral appliance and CPAP in severe OSA patients
• TAP reduced average AHI from 39 to 7.8 — an 80% reduction
• Outcomes comparable to CPAP in measures of sleepiness and quality of life
• One of the most cited studies in the field of dental sleep medicine

Even for patients with severe sleep apnea: TAP delivered an 80% reduction in breathing interruptions — in a device you wear like a mouthguard.

Key finding: Key finding: TAP achieved an 80% AHI reduction (from 39 to 7.8) with outcomes comparable to CPAP across multiple measures, and consistently better patient compliance.

• Retrospective analysis of real-world TAP outcomes across OSA severity levels
• 72% of CPAP-intolerant patients with moderate-to-severe OSA achieved major improvement
• Identifies which patients benefit most from mandibular advancement therapy
• Supports TAP as effective even in more complex clinical presentations

Told your apnea is too severe for an oral appliance? This study says otherwise — 72% of complex cases saw major improvement with TAP.

Key finding: 72% of CPAP-intolerant patients with moderate-to-severe OSA achieved significant clinical improvement with TAP.

• Systematic review of 20 randomized controlled trials and six cohort studies comparing different MAD designs in OSA treatment
• Showed favorable outcomes of midline traction appliances (TAP)
• Monoblock appliances performed more favorably, compared to bilateral thrust

Looking for the easiest and most effective MAD design? This systematic review ranks midline devices at the top. Plus, TAP is easy to adjust with its single point midline advancement.

Key finding: Midline traction appliances (TAP) performed more favorably than other oral appliance designs.

• First randomized controlled trial of TAP’s Mouth Shield in snoring patients
• Mouth Shield promotes nasal breathing — the healthier, more restorative breathing pattern
• Significantly improved patient comfort and treatment compliance
• Reduces dry mouth and helps patients stay in therapy longer

Wake up with a dry mouth? TAP’s Mouth Shield helps you breathe through your nose all night — and actually enjoy wearing your device.

Key finding: TAP’s Mouth Shield significantly improved nasal breathing and treatment compliance in patients who snore.

• Case report of TAP combination therapy in a high-complexity OSA patient
• Patient had both severe OSA and paroxysmal atrial fibrillation
• Immediate positive effects on cardiac electrophysiology and hemodynamics observed
• Expands TAP’s clinical relevance into cardiovascular health outcomes

Treating your sleep apnea isn’t just about snoring less — it may also protect your heart. TAP’s benefits go further than most people expect.

Key finding: TAP therapy showed immediate positive effects on cardiac function — expanding its role beyond airway management.

• researchers wanted to learn how snoring negatively affects breathing and cognitive function
• TAP + Mouth Shield improved cognition (MoCA scores) in 71% of those with mild cognitive impairment and half of those with Alzheimer’s disease
• Decreased snoring was recorded in all study groups

A person’s quality of sleep is extremely important for brain health. With a little extra help at night, you may improve not just the snoring, but also your mental sharpness!

Key finding: Dual therapy (TAP + Mouth Shield) can slow down the onset of Alzheimer’s Disease.